Entrada Therapeutics shares owned by Redmile Group
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Redmile Group
from 13F filings
Historical chart of Redmile Group investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Entrada Therapeutics by Redmile Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $19M | 1.3M | 15.09 |
2023-09-30 | $20M | 1.3M | 15.80 |
2023-06-30 | $20M | 1.3M | 15.14 |
2023-03-31 | $27M | 1.8M | 14.50 |
2022-12-31 | $25M | 1.9M | 13.52 |
2022-09-30 | $31M | 2.0M | 15.76 |
2022-06-30 | $24M | 2.0M | 12.18 |
2022-03-31 | $18M | 2.0M | 9.39 |
2021-12-31 | $34M | 2.0M | 17.12 |